JNJ

Johnson & Johnson (JNJ)

Last Price$159.61.1%
Market Cap$383.4B
LTM Return on Invested Capital (ROIC)
11.6%
5Y avg
17.0%
Drug Manufacturers - General industry median
15.4%
Stock quality & Intrinsic value
6/10
0.2% undervalued

Johnson & Johnson Return on Invested Capital (ROIC)

Annual
Quarterly
LTM
Industry median
Company stand-alone
JNJ
Healthcare
Crunching data... Almost there!
Jan'05Jan'06Dec'06Dec'07Dec'08Jan'10Jan'11Jan'12Dec'12Dec'13Dec'14Jan'16Jan'17Dec'17Dec'18Dec'19Jan'21Jan'22Jan'23Dec'23
Return on Invested Capital (ROIC)
31.0%
35.9%
25.4%
29.1%
21.9%
20.6%
17.9%
23.4%
16.1%
17.1%
16.7%
15.1%
19.1%
(2.2%)
11.4%
11.5%
12.9%
16.1%
18.2%
20.3%
JNJ
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for JNJ and see if it's the right time to invest.
Dive in

Johnson & Johnson (JNJ) Return on Invested Capital (ROIC) comparison analysis

Crunching data... Almost there!

JNJ key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Johnson & Johnson's Return on Invested Capital (ROIC)?

As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is 11.6%, based on the financial report for Dec 29, 2024 (Q4 2024). The average annual Return on Invested Capital (ROIC) for Johnson & Johnson have been 17.3% over the past three years, and 17.8% over the past five years.

2) Is Johnson & Johnson's Return on Invested Capital (ROIC) Good?

As of today, Johnson & Johnson's Return on Invested Capital (ROIC) is 11.6%, which is lower than industry median of 15.4%. It indicates that Johnson & Johnson's Return on Invested Capital (ROIC) is Bad.

3) How does Johnson & Johnson's Return on Invested Capital (ROIC) compare to its peers?

As of today, Johnson & Johnson's Return on Invested Capital (ROIC) is 11.6%, which is lower than peer median of 16.5%. The list of peers includes LLY, GILD, MRK, PFE, NVS, AZN, BMY, AMGN, ABBV, SNY.